Pazoo, Inc. is a health and wellness company. The Company is engaged in providing infrastructure and analytical services to legally authorized distributors and producers of organic medicines and to regulators tracking their operations. Its line of business relating to and revolving around the cannabis industry. It holds an interest in MA & Associates LLC, a testing lab providing laboratory testing of cannabis.

Employees

Sector

Healthcare Facilities & Services

More about the company

22-10-27	Mark Sarna entered into a Letter of Intent to acquire a 20% stake in MA & Associates, LLC from Pazoo, Inc. for $0.995747 million.	CI
20-09-09	An unknown buyer acquired an additional 10% stake in MA & Associates, LLC from Pazoo, Inc. for $0.23 million.	CI

Market Cap	1.07M 923K 862K 791K 1.49M 102M 1.51M 10.11M 3.97M 50.89M 4.01M 3.92M 168M	P/E 2016	-0.01x	P/E 2017	-0.03x
Enterprise Value	4.11M 3.56M 3.32M 3.05M 5.73M 391M 5.82M 38.98M 15.3M 196M 15.45M 15.11M 649M	EV / Sales 2016	127x	EV / Sales 2017	-
Free-Float	99.91%	Yield 2016 *	-	Yield 2017	-

22-10-27	Mark Sarna entered into a Letter of Intent to acquire a 20% stake in MA & Associates, LLC from Pazoo, Inc. for $0.995747 million.	CI
20-09-09	An unknown buyer acquired an additional 10% stake in MA & Associates, LLC from Pazoo, Inc. for $0.23 million.	CI
17-12-30	An undisclosed buyer completed the acquisition of 70% membership interests in MA & Associates LLC from Pazoo, Inc. (OTCPK : PZOO).	CI
17-11-29	An undisclosed buyer entered into an agreement to acquire 70% membership interests in MA & Associates LLC from Pazoo, Inc. (OTCPK : PZOO) for $1.5 million.	CI
17-09-15	Pazoo, Inc. Announces Executive Changes	CI
17-04-03	Pazoo, Inc. cancelled the transaction announced on April 4, 2014	CI
16-07-14	Pazoo, Inc Implements New Validating of Testing	CI
16-06-18	Industrial Hemp and Medical Marijuana Consulting Company Signs Agreement with Pazoo	CI
16-04-26	Pazoo, Inc. will Change its Ticker to PZOO from PZOOD	CI
16-03-30	Pazoo, Inc. will Change its Ticker to PZOO from PZOO.D	CI
16-03-15	Pazoo, Inc. Receives Second Six Figure Loan from Two Individual Investors	CI
15-11-09	Pazoo Begins Generating Consulting Based Revenue with the Signing of Operational Advisory Agreement for Denver Colorado Testing Lab	CI
15-07-09	Pazoo, Inc. Signs Distribution Agreement with Pure Grow Systems, LLC	CI

22-10-28	PAZOO, INC. : Entry into a Material Definitive Agreement (form 8-K)	AQ
20-12-07	PAZOO : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	AQ
18-11-14	Pazoo : Posts Conference Call Recording	PR
18-10-31	Pazoo, Inc. : Will Hold Conference Call Thursday November 8, 2018/Pazoo Website Back Up	PR
18-10-11	Pazoo : MA & Associates LLC Accepts First Samples and Begins Testing	PR

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
NATERA, INC.	+21.37%	+20.29%	+111.98%	+510.96%	46.43B
LABCORP HOLDINGS INC.	+0.83%	+3.22%	+20.06%	+49.24%	25.88B
SONIC HEALTHCARE LIMITED	+0.04%	+1.78%	-19.56%	-35.04%	7.76B
RADNET, INC.	+6.20%	+13.49%	+35.65%	+128.20%	5.69B
DR. LAL PATHLABS LIMITED	+0.19%	+1.39%	+21.09%	+63.03%	3.39B
GENEDX HOLDINGS CORP.	+10.76%	+18.38%	-26.68%	+1,059.10%	2.3B
NEOGENOMICS, INC.	+6.49%	+8.37%	+185.69%	+8.16%	2.13B
FLEURY S.A.	+11.67%	+10.56%	+32.06%	+23.05%	2.02B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	+3.35%	+4.36%	-4.07%	-55.62%	1.99B
Average	+6.77%	+8.67%	+39.58%	+194.56%	10.84B
Weighted average by Cap.	+11.46%	+12.15%	+63.85%	+287.47%

Pazoo Inc Stock Other OTC

Stocks

US70454Q1067

Healthcare Facilities & Services

Valuation: Pazoo Inc

Latest news : Pazoo Inc

Press Releases: Pazoo Inc

Managers and Directors: Pazoo Inc

Medical & Diagnostic Laboratories

Financials

Company Profile

	2016	2017
Net sales	30.52K 26.4K 24.65K 22.61K 42.53K 2.9M 43.21K 289K 114K 1.46M 115K 112K 4.81M	-
Net income	-8.8M -7.61M -7.1M -6.52M -12.26M -837M -12.45M -83.36M -32.72M -420M -33.03M -32.31M -1.39B	-3.54M -3.07M -2.86M -2.63M -4.94M -337M -5.02M -33.59M -13.19M -169M -13.31M -13.02M -559M
Net Debt	3.44M 2.98M 2.78M 2.55M 4.8M 328M 4.88M 32.64M 12.81M 164M 12.93M 12.65M 543M	3.05M 2.64M 2.46M 2.26M 4.25M 290M 4.31M 28.87M 11.33M 145M 11.44M 11.19M 480M

End-of-day quote Other OTC Other stock markets
- ^USD	-